C ertain congenital anomalies of adult-onset hydrocephalus share clinical symptoms with idiopathic normal pressure hydrocephalus (iNPH), such as long-standing overt ventriculomegaly, aqueductal stenosis, 29 and Blake's pouch cyst. 8 However, no disease-associated gene mutations have been identified, including those responsible for these congenital diseases. Moreover, although L1CAM mutations can cause aqueductal stenosis, patients carrying these mutations have clinical features different from patients with NPH. obJect The authors' goal in this paper is to provide the first clinical, radiological, and genetic studies of panventriculomegaly (PaVM) defined by a wide foramen of Magendie and large cisterna magna. methods Clinical and brain imaging data from 28 PaVM patients (including 10 patients from 5 families) were retrospectively studied. Five children were included. In adult patients, the age at onset was 56.0 ± 16.7 years. Tetraventricular dilation, aqueductal opening with flow void on T2-weighted images, and a wide foramen of Magendie and large cisterna magna (wide cerebrospinal fluid space at the fourth ventricle outlet) were essential MRI findings for PaVM diagnosis. 3D fast asymmetrical spin echo sequences were used for visualization of cistern membranes. Time-spatial labeling inversion pulse examination was performed to analyze cerebrospinal fluid movement. Copy number variations were determined using high-resolution microarray and were validated by quantitative polymerase chain reaction with breakpoint sequencing. results Adult patients showed gait disturbance, urinary dysfunction, and cognitive dysfunction. Five infant patients exhibited macrocranium. Patients were divided into 2 subcategories, those with or without downward bulging third ventricular floors and membranous structures in the prepontine cistern. Patients with bulging floors were successfully treated with endoscopic third ventriculostomy. Genetic analysis revealed a deletion in DNAH14 that encodes a dynein heavy chain protein associated with motile cilia function, and which co-segregated with patients in a family without a downward bulging third ventricular floor. conclusions Panventriculomegaly with a wide foramen of Magendie and a large cisterna magna may belong to a subtype of congenital hydrocephalus with familial accumulation, younger age at onset, and symptoms of normal pressure hydrocephalus. In addition, a family with PaVM has a gene mutation associated with dysfunction of motile cilia.
several unique characteristics with an apparent congenital etiology. We describe detailed clinical, radiological, and genetic features in 28 patients.
methods ethics statement
The institutional review boards of Juntendo University Hospital and Yokohama City University School of Medicine approved the study protocol. All patients gave their written informed consent to participate in this study.
diagnostic criteria and participants
Patients were recruited from January 1, 2009, to October 31, 2013 . A diagnosis of PaVM was made using MR imaging. The inclusion criteria were 1) tetraventricular dilation, 2) aqueduct opening with flow void on T2-weighted images, and 3) a wide foramen of Magendie and large cisterna magna on MR imaging (wide CSF space at the fourth ventricle outlet).
Twenty-eight patients (16 males and 12 females), including 5 younger than 10 years, with PaVM incorporating a wide foramen of Magendie and a large cisterna magna, were identified from the Department of Neurosurgery at Juntendo University and other associated hospitals. In adult patients, the age at onset was 56.0 ± 16.7 years. Of the total 28 patients, 10 patients were from 5 families (Table 1 and Fig. 1 ). Two unaffected controls were also included for genetic analysis. Two autopsied brains from another 2 unaffected controls were used for immunostaining.
clinical analysis
Medical records and neuroradiological examinations of all patients were retrospectively analyzed by 2 neurosurgeons (H.K. and M.M.). Clinical characteristics were GD, UD  +  ETV, LPS  NP  GR  16  Sporadic  49, F  GD  NI  ETV  NP  GR  17  Sporadic  48, F  GD  +  ETV  NP  GR  18  Sporadic  73, F  GD, UD  +  ETV  NP  GR  19  Sporadic  20, M  None  +  None  NP  NC  20  Sporadic  8, F  Macrocephaly  +  ETV  NP  GR  21  Sporadic  68, M  GD, UD  +  ETV  NP  GR  22  Sporadic  6, M  Macrocephaly  +  ETV  NP  GR  23  Sporadic  3, F  Macrocephaly  +  ETV  NP  GR  24  Sporadic  67, M  GD  +  ETV, LPS  NP  GR  25  Sporadic  39, F  Headache  +  ETV  NP  GR  26  Sporadic  36, F  Headache  +  ETV  NP  GR  27  Sporadic  45, F  Headache  +  None  NP  NC  28 Sporadic 9, M Macrocephaly + None NP NC CD = cognitive dysfunction; GD = gait disturbance; GR = good recovery; NC = no change; NI = no information; NP = not performed; prepontine membrane = membranous structures in prepontine cisterns; UD = urinary dysfunction; + = present; − = absent. investigated, focusing on the age at disease onset, sex, earliest symptoms, the 3 major symptoms of NPH (dementia, incontinence, and gait disturbance), and surgical procedures (if performed) including ventriculoperitoneal (VP) shunting, lumboperitoneal (LP) shunting, and endoscopic third ventriculostomy (ETV).
magnetic resonance imaging analysis
Imaging was performed using a field strength of 1.5 T (Toshiba) or 3 T (Philips Healthcare). T2-weighted imaging findings (including 3D fast asymmetrical spin echo sequence [3D-FASE] and FLAIR images) were recorded. 3D-FASE is commonly used for heavily T2-weighted MR cisternography. 28 In some patients, time-spatial labeling inversion pulse (time-SLIP) examinations were also performed, and CSF movement visualized as previously described. 42 The shape of the third ventricle floor was examined in sagittal sections from T2-weighted images. The arachnoid membrane of the interpeduncular and prepontine cisterns was examined in 3D-FASE sagittal sections from some patients. Membranous structures in cisterns were clearly visualized by heavily T2-weighted MR cisternography. 13 
dna extraction
Genomic DNA was extracted from peripheral blood or saliva. PAXgene DNA tubes (PreAnalytiX GmbH) were used for peripheral blood sampling, and genomic DNA was extracted using a PAXgene Blood DNA kit (Qiagen) according to the manufacturer's instructions. Salivary DNA was collected using an Oragene DNA Sample Collection Kit (Oragene-DNA, Genotek).
microarray detection of copy number variation
Genome-wide DNA copy number analysis was performed using a Cytoscan HD Array (Affymetrix) according to the manufacturer's protocol. Two patients from Family 1 (Fig. 1A) , 2 patients from Family 2 (Fig. 1B) , and 3 patients from Family 3 (Fig. 1C) were examined. Data were analyzed using Chromosome Analysis Suite software (ChAS; Affymetrix). The copy number variation (CNV) detection conditions were as follows: for duplications, a confidence value of ≥ 90%, 20 or more contiguous probes, and > 100-kb nucleotide length; and for deletions, a confidence value of ≥ 88%, 20 or more contiguous markers, and > 10-kb nucleotide length. 12 Segmental duplications and regions registered in the Database of Genomic Variants (DGV; http://dgv.tcag.ca/dgv/app/home) were excluded as pathological CNV candidates.
Quantitative polymerase chain reaction (taqman copy number assays)
To confirm copy number quantification, TaqMan quantitative polymerase chain reaction (qPCR) using an ABI7900 real-time PCR system (Applied Biosystems) was performed on 3 patients (III-1, III-2, and IV-2) and an unaffected member (II-5) from Family 1 (Fig. 1A) . Four DNAH14 probes were used: Hs 04193802_cn (exon 26), Hs 03354837_cn (exon 29), Hs 03356634_cn (exon 30), and Hs 03375696_cn (exon 39). TaqMan Copy Number Reference assay RNase P (Life Technologies) was used according to the manufacturer's instructions. CNVs were analyzed using ABI7900 Software (Applied Biosystems) and Copy Caller Software version 2.0 (Applied Biosystems).
deletion breakpoint pcr
Primers were designed to span the deleted region of DNAH14 based on the microarray results: forward primer 5'-TCAGGTCATTTTTCTACCACCA-3' and reverse primer 5'-CACAGATTTTTAACACACATTTGGA-3' . The PCR mixture containing ExTaq polymerase (Takara Bio) with 0.5 mM of each primer, 10× ExTaq Buffer (20 mM 
Mg
2+ plus), 2.5 mM each dNTP, and 1 ml ligated DNA was cycled 35 times at 94°C for 30 seconds, 60°C for 1 minute, and 74°C for 1 minute, and then sequenced using an ABI3500xL Genetic Analyzer (Life Technologies) using BigDye Terminator chemistry version 3.1 (Applied Biosystems). Sequences were analyzed using the Sequencher program (Gene Codes).
Double Immunofluorescence Staining
Paraffin sections of autopsied human brains from 2 unaffected controls were double immunostained for candidate gene products. Staining was performed using a rabbit polyclonal antibody to the dynein heavy chain protein of motile cilia, DNAH14 30 (1:50; Sigma-Aldrich), or a mouse monoclonal antibody to the cilia a-tubulin protein 27 (1:500; Sigma-Aldrich). Staining was performed overnight at 4°C. For double labeling, sections were incubated with 2 secondary antibodies for 1 hour at room temperature: Alexa 488 donkey anti-mouse IgG (Molecular Probes, Inc.) and Alexa 594 donkey anti-rabbit IgG (Molecular Probes, Inc.). Nuclei were stained using ProLong Gold Antifade Reagent with 4' ,6-diamidino-2-phenylindole (Molecular Probes, Inc.). Sections were viewed, and images were captured using a Leica TCS SP5 confocal microscope (Leica Microsystems) with Leica Application Suite Advanced Fluorescence Lite 2.4.1 imaging-processing software (Lei ca Microsystems).
results clinical course
The most common symptom in adult PaVM patients was gait disturbance (57%), although incontinence (39%) and cognitive dysfunction (30%) were also common (Table 1). Five affected children exhibited macrocranium. Hydrocephalus was incidentally diagnosed in 3 patients based on MR imaging analysis.
mr imaging analysis
All patients exhibited ventricular dilation (Evans' index 0.38 ± 0.06). Tightness of high-convexity sulci was not detected in PaVM patients ( Fig. 2C and H Patients were divided into 2 groups by the presence or absence of a downwardly bulging third ventricular floor (Table 1) . Seventeen patients showed a downward bulging third ventricular floor. Of these, all patients who were checked had membranous structures in the prepontine cistern on 3D-FASE paramedian sagittal sections (Fig.  2K) . Patients without a downward bulging third ventricular floor lacked these membranes. We did not obtain 3D-FASE paramedian sagittal sections from 5 patients; therefore, we were unable to check for membranes in these patients. Interestingly, CSF movement was restricted in the prepontine cistern of patients with bulging third ventricular floors (Video 2). Patients without bulging third ventricular floors showed CSF movement in the prepontine cistern (Video 1).
therapeutic procedures
Patients with a downward bulging third ventricular floor were treated with ETV (14 of 17 patients). Of these patients, LP shunt treatment was also performed in 2 patients after ETV because the ETV was insufficient. Patients without a downward bulging third ventricular floor were treated with an LP shunt or VP shunt (8 of 11 patients). Six patients were under observation but did not undergo surgery.
cnv detection
Microarray analysis identified CNV that did not overlap with segmental duplications. In Family 1, a 322-kb heterozygous deletion at 1q42.12 (UCSC Genome Browser, chromosome 1: 225,186,483-225,509,460) was detected in 2 patients (III-1 and III-2), but was absent in the mother of these patients (II-5) and 2 healthy controls. No pathogenic CNVs were detected in Family 2 or Family 3 (Fig. 3A) .
All 3 patients in Family 1 carried this deletion, as shown by qPCR analysis (Fig. 3B) . PCR products specific for the deleted allele were amplified in all 3 patients, but not in 3 unaffected members of Family 1 (Fig. 3C) . Sequencing the PCR products revealed that the deletion was 319,330 bp in size (UCSC Genome Browser, chromosome 1: 225,190,746-225,510,076 bp) (Fig. 3D) . This deletion has not been previously reported in DGV, but at least 5 CNVs partially overlapped with this deletion that incorporates DNAH14 exons (Fig. 4) .
immunostaining of autopsied brain
Staining of the autopsied control brains revealed that DNAH14 specifically localized to ependymal cells and choroid plexus epithelial cells (Alexa594; Fig. 5, red) , and a-tubulin localized to ependymal cells, choroid plexus epithelial cells, and ependymal cilia at the interface between the parenchyma and CSF space.
discussion
Our PaVM patients presented with unique clinical features. Although PaVM shared major symptoms with iNPH, age of onset, surgical options, and familial accumulation were different (Table 2 ). Age at onset in our patient group (56.0 ± 16.7 years) was younger than that reported for iNPH (75 years). 24 The majority of iNPH patients typically show ventriculomegaly with tightness of high-convexity sulci. 2, 16, 18 This type of iNPH is currently called disproportionately enlarged subarachnoid space hydrocephalus (DESH). 2, 16 Although components of adultonset PaVM may be included in iNPH, PaVM patients show distinct characteristics compared with those with DESH ( Table 2) .
Twelve patients underwent ETV treatment alone. Kehler et al. showed that downward bulging third ventricular floors are associated with effectiveness of ETV treatment in cases of communicating hydrocephalus. 19 Bulging reflects the pressure gradient between the third ventricle and interpeduncular/prepontine cisterns. 20 In our patients, many with bulging third ventricular floors had prepontine membranes. Because these membranes might be associated with the pressure gradient, we removed them through the third ventricle stoma. In the present study, LP shunt or VP shunt treatment alone was performed in 7 patients without downward bulging third ventricular floors. LP shunt treatment was also performed after ETV because ETV treatment was not effective. Thus, we may have included 2 separate clinical entities with the same radiological features, except for the shape of the third ventricle.
Our MR imaging analysis suggests that PaVM in the present study resembles Blake's pouch cyst. 8 This incorporates the spectrum of posterior fossa cysts and cyst-like malformations that were first reported in 1996 36 and includes the following radiological characteristics: tetraventricular hydrocephalus, infra-or retrocerebellar cyst lo- calization, nonrotated cerebellar vermis, cystic dilation of the fourth ventricle without cisternal communication, and degree of compression on medial cerebellar hemispheres. 8 Two features are different, however. First, Blake's pouch cyst involves cystic dilation of the fourth ventricle, which was not seen in our PaVM patients. Second, Blake's pouch cyst is an obstructive hydrocephalus without cisternal communication, but our time-SLIP examinations and effectiveness of LP shunting suggest that PaVM is a communicating hydrocephalus.
Familial occurrence of iNPH is uncommon, having previously been reported only 4 times. 25, 32, 34, 43 No causative mutations were identified in these families. In the present study, the observed familial occurrence suggests possible involvement of a genetic factor. Copy number analysis identified a deletion involving DNAH14, which encodes an axonemal dynein heavy chain protein involved in microtubule binding and conversion of adenosine triphosphate energy to force, chiefly in motile cilia.
According to the BioGPS database (http://biogps.org), DNAH14 is expressed throughout the human body. Its discrete localization in the ventricular system and subarachnoid space has never been shown. Here, our immunohistochemical analysis revealed DNAH14 to be abundantly localized in ependymal cells and choroid plexus epithelial cells. This suggests that DNAH14 deletion may affect physiological function of cilia during hydrocephalus pathogenesis. CSF production or absorption may be disturbed in the ependyma or choroid plexus. However, the exact pathophysiological details of the hydrocephalus associated with motile cilia in our patients remain unclear.
Dysfunction in dynein heavy chain families is asso- ciated with primary ciliary dyskinesia, 26 which presents with respiratory infection, situs inversus, and sometimes hydrocephalus. Cases of primary ciliary dyskinesia-associated hydrocephalus in humans have previously been reported, although the causative mutations have not been identified. 3, 6, 10, 14, 21, 31, 37, 39 We observed a pathogenic CNV involving DNAH14 in only one family in the present study, although it is possible that techniques such as next-generation sequencing would identify other hydrocephalus-associated mutant genes in these patients, including those in Family 1. CNV involving DNAH14 had been reported in DGV (Fig. 4) 
conclusions
Panventriculomegaly with a wide foramen of Magendie and a large cisterna magna exhibits unique characteris- tics distinct from other types of hydrocephalus with NPH symptoms (e.g., DESH, aqueductal stenosis, and Blake's pouch cyst); specifically, imaging findings, younger age at onset, tractability to ETV treatment, and familial accumulation. Thus, PaVM likely belongs to a separate clinical entity. PaVM can be divided into 2 subcategories: with or without bulging of the third ventricular floor. A portion of PaVM cases may be associated with genetic factors that include a DNAH14 abnormality. The microarray analysis was supported in part by the Laboratory of Molecular and Biochemical Research (Research Support Center, Juntendo University Graduate School of Medicine, Tokyo, Japan) and the Juntendo University Research Institute for Diseases of Old Age (Tokyo, Japan). The confocal microscope study was supported in part by the Division of Biomedical Imaging Research (Research Support Center, Juntendo University Graduate School of Medicine, Tokyo, Japan). In particular, we thank M. Kunichika from this division for preparing the autopsied brain paraffin sections. 22, 40 Gene mutations in human DNAH14 Unidentified Unidentified L1CAM (X-linked) 1, 40 AR = autosomal recessive; tetra = tetraventricular dilation.
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